BANGKOK CHAIN HOSPITAL PUBLIC COMPANY LIMITEDSET: BCH🇹🇭 TH

CG Structure · 2025

Board Composition

Total Number of Directors

12

Male Directors

9

Female Directors

3

Independent Directors

4

Non-executive Directors

5

Non-executive Directors Who Are Not Independent

1

Executive Directors

7

Total Board Meetings Held

5

Board of Directors

Directors

TitleTitle — Please SpecifyFirst NameLast NameGenderYear of BirthNationalityResident in Thailand?PositionExecutive or Non-executiveIndependent Director?Director TypeAppointment DateAuthorised to Sign?Related to Another Director or Executive?Any Legal Violation in the Past 5 Years?Highest EducationField of StudySkills & ExpertiseDirector TrainingAttended Director Training?Director Accreditation Program (DAP)?Director Certification Program (DCP)?Board Meetings HeldBoard Meetings AttendedAGMs HeldAGMs AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary RemunerationShares HeldShareholding (%)Shares Held by Related Persons (s.59)Shareholding by Related Persons (s.59, %)Indirect Shareholding (held by whom)Shareholding Details (URL)
otherAsst. Prof. Dr. SOMPORNHARNPHANICH, M.D.F1,952643 · Description: ThailandYChairman of the boardExecutiveContinuing director (Full term of directorship and being re-appointed as a director)1993-11-24T00:00YYNDoctoral degreeMedicine134 · Description: Health Care Services · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration · 147 · Description: Sustainability2024 · Description: Hospital Management · 2025 · Description: Mastering the Dynamic of Xcellence · 2024 · Description: Strategic Human Resource Management Programme, Human Resource Institute · 1730 · Year: 2004 · Description: Director Accreditation Program (DAP) · 1736 · Year: 2013 · Description: Role of the Chairman Program (RCP) · 2025 · Description: Hospital Costing and Business Planning for Financial Management YYN5511700,000566,2001,266,20000164,014,7416.58813,750,00032.63Spousehttps://www.set.or.th/en/market/product/stock/quote/BCH/major-shareholders
otherProf. Dr. CHALERMHARNPHANICH, M.D.M1,954643 · Description: ThailandYDirectorExecutiveExisting director1993-11-24T00:00YYNDoctoral degreeMedicine134 · Description: Health Care Services · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration2024 · Description: Political Governance for Senior Executives · 2024 · Description: Rule of Law for Democracy · 2024 · Description: Senior Executive Programme in Administrative Justice · 2024 · Description: Advanced Insurance Studies · 2024 · Description: Business Reform and Innovation Network Building · 2024 · Description: Senior Executive Justice Process Management · 2024 · Description: Super Leadership in Advanced Insurance Studies · 1730 · Year: 2004 · Description: Director Accreditation Program (DAP) · 1731 · Year: 2005 · Description: Director Certification Program (DCP) · 2024 · Description: Hospital Management · 2025 · Description: Super Leader Business and LawYYY5511700,000566,2001,266,20000813,750,00032.63164,014,7416.58Spousehttps://www.set.or.th/en/market/product/stock/quote/BCH/major-shareholders
otherDr.PORNLUCKHARNPHANICH, M.D.F1,985643 · Description: ThailandYDirectorExecutiveExisting director2012-08-10T00:00YYNDoctoral degreeBusiness Administration134 · Description: Health Care Services · 165 · Description: Risk Management · 1683 · Description: Business Administration · 265 · Description: Governance/ Compliance · 147 · Description: Sustainability2024 · Description: Mastering the Dynamic of Xcellence · 2024 · Description: Mini Master of Management in Health · 2024 · Description: Oxford Program on Negotiation in Bangkok Said Business School, University of Oxford · 2024 · Description: Leading Sustainable Corporation Program, Said Business School, University of Oxford · 2024 · Description: Entrepreneurial Finance · 2025 · Description: Hospital Costing and Business Planning for Financial Management · 2023 · Description: Executive Training Program on Administrative Justice · 1730 · Year: 2013 · Description: Director Accreditation Program (DAP) · 1739 · Year: 2013 · Description: Successful Formulation & Execution of Strategy (SFE)YYN5511700,000566,2001,266,2000089,578,4193.5900https://www.set.or.th/en/market/product/stock/quote/BCH/major-shareholders
Mr.KANTAPORNHARNPHANICHM1,987643 · Description: ThailandYDirectorExecutiveExisting director2015-04-28T00:00YYNMaster's degreeBusiness Administration142 · Description: Marketing · 154 · Description: Digital Marketing · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration1730 · Year: 2012 · Description: Director Accreditation Program (DAP) · 2024 · Description: Successful Formulation & Execution of Strategy · 2024 · Description: Oxford Program on Negotiation in Bangkok Said Business School, University of Oxford · 2025 · Description: Human Subject Protection (HSP) YYN5511700,000566,2001,266,2000089,578,4193.598000Spousehttps://www.set.or.th/en/market/product/stock/quote/BCH/major-shareholders
otherDr.PORNSUDA HARNPHANICHF1,989643 · Description: ThailandYDirectorExecutiveExisting director2020-01-13T00:00YYNDoctoral degreeBusiness Administration144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration · 147 · Description: Sustainability2024 · Description: Mastering the Dynamic of Xcellence · 2024 · Description: Finance for HR executive · 2024 · Description: Compensation and benefits design · 2024 · Description: Oxford Programme on Negotiation in Bangkok Said Business School, University of Oxford · 2024 · Description: AI for Healthcare: Equipping the workforce for digital transformation, The University of Manchester and Health Education · 2024 · Description: Human Resources Management Course, Oxford Home Study College · 2024 · Description: Supply Chain Management Course, Oxford Home Study College · 2024 · Description: Oxford Leading Sustainable Corporations Program, Said Business School, University of Oxford · 2025 · Description: Certified Investment and Securities Analyst Program (CISA), Foundation Knowledge Level: Accredited Investment and Securities Analyst · 1730 · Year: 2015 · Description: Director Accreditation Program (DAP) · 2025 · Description: Hospital Costing and Business Planning for Financial ManagementYYN5511700,000566,2001,266,2000089,578,4213.5900https://www.set.or.th/en/market/product/stock/quote/BCH/major-shareholders
Mr.PHINIJHARNPHANICHM1,956643 · Description: ThailandYDirectorNon-executiveNExisting director2017-02-27T00:00NYNMaster's degreePolitical Science165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration1730 · Year: 2024 · Description: Director Accreditation Program (DAP)NYN5511700,000566,2001,266,200000000
Mr.VORAVEEKIATINIYOMSAKM1,979643 · Description: ThailandYDirectorExecutiveContinuing director (Full term of directorship and being re-appointed as a director)2020-06-23T00:00NNNMaster's degreeBusiness Administration143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration1730 · Year: 2020 · Description: Director Accreditation Program (DAP) · 2019 · Description: Strategic CFO in Capital Market · 2020 · Description: TFRS for NPAEs Update · 2024 · Description: CFO 2025 (Tax) · 2019 · Description: TFRS16 · 2025 · Description: Mastering the Dynamic of Xcellence · 2024 · Description: Stock valuation in the new era of business · 2016 · Description: Fundamentals for Corporate SecretariesYYN5511700,000566,2001,266,200000000
otherMr.SURAPANTTAWEEWIKAYAKARN, M.D.M1,961643 · Description: ThailandYDirectorExecutiveContinuing director (Full term of directorship and being re-appointed as a director)2023-02-28T00:00NNNMaster's degreeMedicine134 · Description: Health Care Services · 265 · Description: Governance/ Compliance · 142 · Description: Marketing · 1683 · Description: Business Administration · 144 · Description: Finance1730 · Year: 2024 · Description: Director Accreditation Program (DAP) · 2024 · Description: Senior Executive Program (Sasin-Kellog school) · 2024 · Description: TITC:JCIA, Infectious control and Hospital design · 2024 · Description: Lead Auditor for ISO 9001:2000, SGS Australia · 2025 · Description: Hospital Cost Analysis and Business Plan for Financial Management · 2023 · Description: Executive Training Program on Administrative Justice · 2024 · Description: Excellent Hospital Director Mini MBAYYN5511700,000566,2001,266,200000000
otherAsst. Prof. Dr. VIRACHAPHIMETEETAMRONGM1,943643 · Description: ThailandYDirectorNon-executiveYExisting director2004-04-09T00:00NNNDoctoral degreeFinance144 · Description: Finance · 143 · Description: Accounting · 165 · Description: Risk Management · 166 · Description: Audit · 265 · Description: Governance/ Compliance1730 · Year: 2003 · Description: Director Accreditation Program (DAP) · 2023 · Description: R-SS: Engaging Board in ESG: The path of Effective Sustainability · 2022 · Description: Hot Issue for Directors: What Directors Need to Know About Digital Assets · 2019 · Description: C-Conference : Collective Action Against Corruption Conference “Innovations in the Fight against Corruption” · 2018 · Description: R-DF : Director Forum “Visionary Board & Announcing 90 Qualified Companies · 2018 · Description: R-CF : Chairman Forum "Digital Transformation - A Must for all Companies" · 2018 · Description: M-DDT : Director Dinner : "Talk Social Responsibility Partnership in Education" · 2018 · Description: NDC : National Director Conference : Rising Above Disruptions : A Call for Action · 2015 · Description: Corporate Governance for Capital Market Intermediaries (CGI) · 2015 · Description: R-CF : Chairman Forum “Chairman Role in Building Independence across the Board” · 2010 · Description: Anti-Corruption for Executive Program (ACEP) · 2010 · Description: R-SS: Special Seminar · 2009 · Description: M-DLB : Director Luncheon Briefing · 2009 · Description: M-AGM : Annual General Meeting NYN5511000000000
Mr.SIRIPONGSOMBUTSIRIM1,955643 · Description: ThailandYDirectorNon-executiveYExisting director2004-04-09T00:00NNNMaster's degreeBusiness Administration166 · Description: Audit · 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance1733 · Year: 2015 · Description: Ethical Leadership Program (ELP) · 1730 · Year: 2003 · Description: Director Accreditation Program (DAP)NYN5511000000000
otherProf. PIPHOBVEERAPHONGM1,962643 · Description: ThailandYDirectorNon-executiveYContinuing director (Full term of directorship and being re-appointed as a director)2004-04-09T00:00NNNMaster's degreeLaw141 · Description: Law · 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance1731 · Year: 2017 · Description: Director Certification Program (DCP) · 1730 · Year: 2006 · Description: Director Accreditation Program (DAP) · 2023 · Description: ESG & Climate Risk Management : Deloitte · 2023 · Description: PDPA update : LH Bank · 2023 · Description: Information Technology Security Awareness Training : LH BankNYY5511000000000
otherMr.THAWATSUNTRAJARN, M.D.M1,948643 · Description: ThailandYDirectorNon-executiveYExisting director2010-04-26T00:00NNNMaster's degreeMedicine134 · Description: Health Care Services · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration1730 · Year: 2024 · Description: Director Accreditation Program (DAP)NYN5511700,000566,2001,266,200000000

Board Meetings & Remuneration

Date of the Annual General Meeting

2025-04-24T00:00

Was an Extraordinary General Meeting Held?

No

Board Meeting Allowance (Baht)

6300000.0

Other Board Remuneration (Baht)

5095800.0

Total Board Remuneration (Baht)

11395800.0

Balance of Power Between the Board and Management

Are There Measures Balancing the Board's and Management's Power?

Yes

Measures Balancing the Board's and Management's Power

The company appointed an independent director to jointly determine the agendas of the Board of Director meetings to ensure compliance with corporate governance code for registered companies in accordance with Principle 3 Strengthen Board Effectiveness that balances power between the management division and the Board of Directors.

In each meeting, the Chairman provides an opportunity for each director to express their opinions independently. In cases where any director has a vested interest in the matter under consideration, he or she is required to inform the meeting, refrain from expressing opinions, and abstain from voting on that specific matter. The minimum quorum required for decision-making at a board meeting is at least two-thirds of the entire board.

Methods Used to Balance Power

Method
Appointment of an independent director Participate in determining the meeting agenda for the committee

Board Roles, Duties and Charter

Does the Company Have a Board Charter?

Yes

Content of the Board Charter

Scope of powers of Board of Directors

The Company's Board of Directors holds authorities, duties, and responsibilities for managing the Company in accordance with laws, company objectives and regulations as well as the resolutions of the shareholder meetings that are lawful in terms of integrity, honesty, and prudence to safeguard the Company's interests. In summary, the key authorities, duties, and responsibilities are as follows:

  1. Arrange the preparation of financial statements, including the profit and loss statements as of the end of the accounting period, which have been audited, and present them at the shareholder meetings for consideration and approval.

  2. The Board may delegate authority to one or more directors or any other persons to perform any specific act on behalf of the Board under its control. The Board may also delegate authority to empower such individuals as the Board deems appropriate, within a timeframe determined by the Board. The Board has the right to revoke, withdraw, modify, or amend designated persons or the authority granted as deemed appropriate. Moreover, the Board may delegate authority to the Executive Committee with specific details within the scope of powers of the Executive Committee. The delegated authority must not involve granting powers that would enable the Executive Committee to consider and approve transactions that may result in the Executive Committee or persons with possible conflicts’ vested interest or conflict of interest with the Company or its subsidiaries, except for approving transactions that align with the policies and criteria previously considered and approved by the Board.

  3. Set goals, guidelines, policies, and budgets, as well as overseeing the management and operations of the Executive Committee in accordance with the assigned policies. Legal matters that require approval from the shareholder meeting before implementation include capital increase, capital reduction, issuance of debentures, sale or transfer of the entire or part of the Company's business to other parties, and the acquisition or transfer of business from other companies, and the amendment to memorandum. Additionally, the Board has responsibilities in supervising the Company to comply with securities and exchange laws and the Stock Exchange’s regulations such as related party transactions, and the buying or selling of significant assets according to the criteria set by the Stock Exchange of Thailand or relevant laws pertaining to the Company's business.

  4. Consideration of the management structure involves appointing the Executive Committee, the Chief Executive Officer, and other committees as deemed appropriate.

  5. Monitor the performances to ensure continuous alignment with strategic plans and budgets.

  6. Consider and approve interim dividend payments to shareholders when the Company has earned sufficient profits to do so. Report the details of such dividend payments at the next shareholder meeting.

  7. Review, approve, and adhere to policies or guidelines related to the Company's anti-corruption, as well as defining responsibilities for executives to manage effective communication to all personnel and stakeholders to ensure acknowledgement and compliance.

Scope of powers of Chairman of the Board of Directors

  1. The Chairman of the Board is responsible for overseeing the implementation of strategic policies and operational guidelines in the management division. This includes providing guidance and support for the management division's business operations but does not involve the daytoday management of the Company.

  2. The Chairman of the Board serves as the chairman at both the Company's board meetings and shareholder meetings. The chairman encourages all board members to participate throughout the meetings, as well as overseeing the board meetings and shareholder meetings to ensure that they are successfully accomplished.

  3. Be responsible as the Chairman of the Board of Directors for overseeing, monitoring, and managing operations of the Board and other subcommittees to achieve the objectives of established plans in accordance with laws, principles of good corporate governance, and business code of conduct and also accountable to relevant shareholders and stakeholders.

  4. Serve as the chairman of the Company's board meetings and shareholder meetings

  5. Cast the deciding vote in the event of a tie vote during the board meetings.

Scope of Powers of Chief Executive Officer

  1. To oversee and manage the day to day operations and/r daily business activities of the Company.

  2. Operate or carry out tasks in accordance with the policies, plans, and budgets approved by the Company’s committee and/r the Executive Committee.

  3. Serve as the authorized representative of the Company in managing its business in accordance with the objectives, regulations, policies, rules, stipulations, orders, resolutions of the shareholder meetings and/r resolutions of the Board meetings and the Executive Committee meetings in all respects.

  4. Have the authority to appoint and manage subcommittees for the benefit and efficiency of good and transparent management, possess the power to subdelegate and/r assign tasks to other individuals to perform any specific act on their behalf, within the scope of authority granted as defined in this power of attorney, and/r in accordance with the regulations, stipulations, or orders prescribed by the Company's Board of Directors and/r the Company.

  5. Define the missions, objectives, guidelines, and policies of the Company, including giving commands and overseeing the overall operations.

  6. Monitor and evaluate the Company's operations consistently to prevent risks from various internal and external factors.

  7. Consider entering into contracts related to the Company’s normal business operations, such as contracts for healthcare services and contracts for medical services in accordance with the Social Security Act B.E.2533 (1990), contracts for medical services within the Universal Health Coverage Scheme and procurement contracts, as well as indicating steps and methods for preparing such contracts, which shall be presented to the Executive Committee and the Board of Directors for acknowledgement.

  8. Have the authority to consider hiring employees, including appointments, transfers, reassignments across departments, or termination of employment. This includes determining salary rates, compensation, bonuses, as well as welfare for all employees of the Company.

  9. Have the authority to issue orders, regulations, announcements, records, to ensure that the operation is carried out in accordance with the policies and for the Company's interest, and to maintain discipline and internal working procedures within the organization.

  10. Perform other duties as from time to time assigned by the Board of Directors.

In order to maximize the efficiency in performing duties, the Chief Executive Officer shall not hold a position in any other listed company. The Chief Executive Officer has the authority to delegate power to individuals as deemed appropriate, excluding the authority and/or delegation of power to approve any transactions that may involve the Chief Executive Officer or persons with possible conflicts’ vested interest, or result in any other form of benefit that conflicts with the Company or its subsidiaries, in accordance with the criteria of the Stock Exchange of Thailand. Such transactions shall be presented to the Board of Directors and/or shareholders meetings for consideration and approval, as stipulated by the Company’s regulations or relevant laws.

Link to the Board Charter

https://www.bangkokchainhospital.com/storage/document/charter/bch-board-of-director-charter-en.pdf

Other Board Governance Matters

Board Governance Practices

PracticeYes / No
The chairman of the board and the highest-ranking executive are from the same personN
The chairman of the board is an independent directorN
The chairman of the board and the highest-ranking executive are from the same familyY
Chairman is a member of the executive board or taskforceY
The company appoints at least one independent director to determine the agenda of the board of directors’ meetingY

Audit Committee

Audit Committee Charter

Roles, Duties and ResponsibilitiesType of SubcommitteeLink to the Charter
Scope of powers, roles, and responsibilities of the Audit Committee as assigned by the Board of Directors and the reporting to the Board are as follows: 1) Review the accuracy, adequate disclosure, and the reliability of the Company's financial reports. 2) Review the suitability and effectiveness of the Company’s internal control system and internal audit. 3) Participate in the evaluation of the qualifications and skills of the Chief Financial Officer and the Director of Accounting Department. 4) Consider the selection, appointment, and approval of remuneration of the firm that provides internal audit services for the Company, taking into account the knowledge, skills, and experience of the personnel of the respective firm, as well as approving the annual internal audit plan. In the case where the Company establishes its own internal audit unit, the Audit Committee shall approve the appointments, transfers, and withdrawals, as well as assessing the annual performance of the personnel responsible for the internal audit unit. 5) Consult and review the audit scope and plan of internal auditors and the Company’s auditors to ensure alignment and coordination 6) Conduct reviews and examinations in collaboration with internal auditors regarding audit findings, observations, and recommendations. 7) Review to ensure that the Company adheres to securities and exchange laws, the Stock Exchange’s regulations, and relevant laws pertaining to the Company's business. 8) Consider, select, propose appointments and remuneration of the Company's auditors, taking into account their independence, reliability, adequacy of resources, and the volume of audit work performed by the respective audit firm. This includes considering the experience of the personnel assigned to conduct the Company's audit, as well as attending meetings with the auditors without the presence of the management division at least once a year. 9) Conduct reviews and examinations in collaboration with internal auditors regarding financial reports, observations, and recommendations. 10) Review to ensure that the Company adheres to its anti-corruption policies. 11) Consider the Company’s information disclosure in cases where there are related party transaction or transactions that may involve conflicts of interest, ensuring accuracy, completeness, and compliance with legal requirements and stock market regulations. This is to ensure that such transactions are reasonable and in the best interest of the Company. 12) Prepare the Audit Committee report to be disclosed in the Company's annual report. The report must be signed by the Chairman of the Audit Committee and include, at a minimum, the following information: - The opinion regarding the accuracy, completeness, and reliability of the Company's financial report - The opinion regarding the adequacy of the Company's internal control system - The opinion regarding the compliance with securities and exchange laws, the Stock Exchange’s regulations, or relevant laws pertaining to the Company's business - The opinion regarding the suitability of the auditors - The opinion regarding potential conflicting of interest - The number of audit committee meetings and the attendance of each member - The overall opinions or observations received by the Audit Committee regarding the fulfillment of duties in accordance with the charter - Other particulars that are deemed necessary for shareholders and general investors to be aware of within the scope of duties and responsibilities assigned by the Company's Board of Directors 13) Any other operations carried out as assigned by the Company's Board of Directors with the approval of the Audit Committee. 14) Possess the authority to conduct audits and inspection as necessary on various matters, including seeking independent professional advice when deemed necessary by the Company's expenses, to ensure the effective fulfillment of duties and responsibilities. 15) Regularly review and amend the audit committee charter annually to ensure the relevance and appropriateness in alignment with the organizational environment. In carrying out the aforementioned duties, the Audit Committee holds direct responsibility to the Board of Directors, while the Board of Directors also bears responsibility for the Company's operations to external parties.
3091 · Description: Audit of financial statements and internal controlshttps://www.bangkokchainhospital.com/storage/document/charter/bch-audit-committee-charter-en.pdf

Audit Committee Members

TitleTitle — Please SpecifyFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudyHas Accounting or Financial Expertise?Skills & ExpertiseMeetings HeldMeetings AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary Remuneration
otherAsst. Prof. Dr. VIRACHAPHIMETEETAMRONGChairman of the audit committeeM1,943643 · Description: ThailandY2004-04-09T00:00Doctoral degreeFinanceY144 · Description: Finance · 143 · Description: Accounting · 165 · Description: Risk Management · 166 · Description: Audit · 265 · Description: Governance/ Compliance55820,000669,0001,489,00000
Mr.SIRIPONGSOMBUTSIRIAudit committeeM1,955643 · Description: ThailandY2004-04-09T00:00Master's degreeBusiness AdministrationY166 · Description: Audit · 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance55760,000617,6001,377,60000
otherProf. PIPHOBVEERAPHONGAudit committeeM1,962643 · Description: ThailandY2004-04-09T00:00Master's degreeLawY141 · Description: Law · 143 · Description: Accounting · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance55760,000617,6001,377,60000

Audit Committee — Meeting Allowance (Baht)

2340000.0

Audit Committee — Other Remuneration (Baht)

1904200.0

Audit Committee — Total Remuneration (Baht)

4244200.0

Executive Committee

Executive Committee Charter

Roles, Duties and ResponsibilitiesType of SubcommitteeLink to the Charter
The Executive Committee has the authorities, duties, and responsibilities to manage the normal operations and administrative tasks of the Company. This includes establishing policies, business plans, budgets, organizational structures, and various administrative powers of the Company. Criteria for conducting business are aligned with the economic conditions to present to the Company's Board of Directors for consideration, approval, and/or endorsement. The committee also oversees and monitors the Company's performance in accordance with the established policies. In summary, the key authorities and responsibilities are as follows: 1) Conduct the Company's operations and manage its affairs in accordance with the objectives, regulations, policies, rules, stipulations, orders, and resolutions of the Board of Directors and/or resolutions adopted at shareholder meetings in all respects. 2) Consider and establish policies, directions, and strategies of the Company's business operations, financial plans, budgets, human resource management, information technology investments, expansion plans, public relations, and governance controls to ensure that the appointed committees achieve their goals to present to the committee meetings for further consideration. 3) Consider the allocation of the annual budget as presented by the management division before presenting it to the Board of Directors for consideration and approval. This includes reviewing and approving changes and additions to the annual expenditure budget during periods without Board of Director meetings and presenting them to the Board for acknowledgement at the next meeting. 4) Approve significant investment expenditures as specified in the annual expenditure budget, as assigned by the Board of Directors or as previously resolved in principle by the Board of Directors. 5) Have the authority to consider and approve loans, credit facilities, or any form of company financing within the limit of 100 million baht per transaction. 6) Have the authority to approve and withdraw funds from all company accounts, utilize credit from any bank or financial institution held by the Company, including opening various accounts and/or requesting credit in various forms from banks or financial institutions. Furthermore, the committee has the authority to pledge various securities of the Company as collateral, whether registered or unregistered. 7) Serve as an advisory body to the management division on matters related to financial policies, marketing, human resource management, and other operating activities. 8) Consider the Company's profit and loss, propose interim or annual dividend payments, and present them to the Board of Directors for approval. 9) Establish the organizational structure, management authority, including appointment, hiring, transfer, remuneration determination, compensation, and bonuses for executive-level employees who do not hold executive director positions. This excludes the Chief Executive Officer and dismissal. 10) Have the authority to delegate authority to one or more directors or any other persons to perform any specific act under the control of the Executive Committee. The committee may also delegate authority to empower such individuals as the Executive Committee deems appropriate, within a timeframe determined by the Executive Committee. The Executive Committee may revoke, withdraw, modify, or amend designated persons or the authority granted as deemed appropriate. 11) Initiate the development of policies or guidelines related to anti-corruption and the creation of values in combating corruption within the Company. 12) Undertake any other tasks assigned from time to time by the Board of Directors. However, the authority of the Executive Committee shall not include the approval of any transactions that may involve conflicts of interest, or transactions in which the Executive Committee or individuals related to the committee have a vested interest or benefit in a manner that conflicts with the Company or its subsidiaries, as per the regulations of the Stock Exchange of Thailand. Such transactions shall be presented to the Board of Directors and/or shareholders meetings for consideration and approval, as stipulated by the Company’s regulations or relevant laws.
3097 · Other name: Manage the normal operations and administrative tasks of The Company · Description: Othershttps://www.bangkokchainhospital.com/storage/document/charter/bch-executive-committee-charter-en.pdf

Executive Committee Members

TitleTitle — Please SpecifyFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudyMeetings HeldMeetings AttendedMeeting Allowance (Baht)Other Remuneration (Baht)Total Remuneration (Baht)Remuneration from Subsidiaries (Baht)Non-monetary Remuneration
otherProf. Dr. CHALERMHARNPHANICH, M.D.Chairman of the executive committeeM1,954643 · Description: ThailandY2004-05-17T00:00Doctoral degreeMedicine4400000
otherAsst. Prof. Dr. SOMPORNHARNPHANICH, M.D.Vice-chairman of the executive committeeF1,952643 · Description: ThailandY2004-05-17T00:00Doctoral degreeMedicine4400000
otherDr.PORNLUCKHARNPHANICH, M.D.Member of the executive committeeF1,985643 · Description: ThailandY2015-10-12T00:00Doctoral degreeBusiness Administration4400000
Mr.KANTAPORNHARNPHANICHMember of the executive committeeM1,987643 · Description: ThailandY2015-10-12T00:00Master's degreeBusiness Administration4400000
otherDr.PORNSUDA HARNPHANICHMember of the executive committeeF1,989643 · Description: ThailandY2016-02-01T00:00Doctoral degreeBusiness Administration4400000
otherMr.SURAPANTTAWEEWIKAYAKARN, M.D.Member of the executive committeeM1,961643 · Description: ThailandY2017-11-08T00:00Master's degreeMedicine4400000
Mr.VORAVEEKIATINIYOMSAKMember of the executive committeeM1,979643 · Description: ThailandY2016-02-01T00:00Master's degreeBusiness Administration4400000
otherMr.DhitiPattanakamjornMember of the executive committeeM1,958643 · Description: ThailandY2006-11-20T00:00Master's degreeBusiness Administration4400000

Executive Committee — Meeting Allowance (Baht)

0.0

Executive Committee — Other Remuneration (Baht)

0.0

Executive Committee — Total Remuneration (Baht)

0.0

Other Subcommittees

Other Subcommittees

Subcommittee NameType of SubcommitteeRoles, Duties and ResponsibilitiesLink to the CharterMeetings HeldSubcommittee RemunerationMembers
Sustainability, Governance and Risk Management Committee3092 · Description: Risk management · 3096 · Description: Sustainability development · 3095 · Description: Corporate governance
1) Establish policies, goals, and practices related to sustainability and corporate governance covering economic, social, and environmental dimensions to support the sustainable business operation in a long run and present them to the Board of Directors for approval, as well as reviewing policies, goals, and practices to align with the Company's operational direction or strategies. 2) Support and promote collaboration in implementing sustainability initiatives throughout the organization by fostering knowledge and understanding among the Board, executives, and employees regarding sustainability, corporate governance, and organizational risk management. Additionally, the committee supports the integration of sustainability operations with the Company's strategies and plans to achieve the organization's sustainability goals. 3) Oversee operations and provide advice and recommendations on sustainability operations, including monitoring performance both internal and external sustainability indicators. Additionally, the committee supervise reporting or disclosure of information related to sustainability. 4) Support, oversee, and monitor operations to ensure compliance with laws, regulations, or stipulations of regulatory and relevant government agencies, as well as upholding good corporate governance principles in alignment with the Company's business code of conduct and good corporate governance principles. 5) Consider, review, and present organizational risk management policies and frameworks to the Board of Directors for consideration. 6) Review and provide approval for acceptable levels of risk, and present them to the Board of Directors for acknowledgment. 7) Oversee the business development and implementation in accordance with organizational risk management policies and frameworks consistently, ensuring that the Company maintains an efficient and continuous organization-wide risk management system. 8) Review organizational risk management reports to monitor significant risks and take actions to ensure that the organization has adequate and appropriate risk management. 9) Coordinate with the Audit Committee regarding critical organizational risks and collaborate with the internal audit department to ensure that the Company has an appropriate internal control system for risk management. This includes adapting and implementing the risk management system appropriately and consistent practices throughout the organization. 10) Report on sustainability operations, corporate governance, as well as organizational risks and significant risk management to the Board of Directors regularly. 11) Consider appointing working groups related to sustainability operations, corporate governance, and risk management as deemed appropriate. This includes defining roles, responsibilities, and accountability to ensure operational alignment with objectives. 12) Provide guidance and advice to the working groups involved in sustainability operations, corporate governance, and risk management, as well as considering appropriate guideline to address various data amendments related to the development of sustainability operations and the enhancement of the organizational risk management system. 13) Perform any other tasks related to sustainability, corporate governance, and risk management as assigned by the Board of Directors.
https://www.bangkokchainhospital.com/storage/document/charter/bch-risk-management-committee-charter-en.pdf6352000.0 · Meeting allowance: 352000.0 · Other remuneration: 0.0262 · Last name: Chaimongkol · Position: 37 · First name: Saifon · Total meeting: 6 · Meeting allowance: 80000.0 · Other remuneration: 0.0 · Total remuneration: 80000.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: HARNPHANICH, M.D. · Position: 39 · First name: SOMPORN · Total meeting: 6 · Title other name: Asst. Prof. Dr. · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: HARNPHANICH, M.D. · Position: 39 · First name: PORNLUCK · Total meeting: 6 · Title other name: Dr. · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: HARNPHANICH · Position: 39 · First name: PORNSUDA · Total meeting: 6 · Title other name: Dr. · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 260 · Last name: KIATINIYOMSAK · Position: 39 · First name: VORAVEE · Total meeting: 6 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: HAHTAPORNSAWAN, M.D. · Position: 39 · First name: Supotjanee · Total meeting: 6 · Title other name: Ms. · Meeting allowance: 68000.0 · Other remuneration: 0.0 · Total remuneration: 68000.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 261 · Last name: Krishnakalin · Position: 39 · First name: Vimonmarn · Total meeting: 6 · Meeting allowance: 68000.0 · Other remuneration: 0.0 · Total remuneration: 68000.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 261 · Last name: Kengkijkarn · Position: 39 · First name: Anchalee · Total meeting: 6 · Meeting allowance: 68000.0 · Other remuneration: 0.0 · Total remuneration: 68000.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: Wongchaisuriya, M.D. · Position: 39 · First name: Thitiporn · Total meeting: 6 · Title other name: Mr. · Meeting allowance: 68000.0 · Other remuneration: 0.0 · Total remuneration: 68000.0 · Total meeting attendance: 6 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0
Nomination and Remuneration Committee3094 · Description: Remuneration · 3093 · Description: Director and executive nomination
1) Establish criteria and processes for selecting individuals with suitable qualifications to serve as directors of the Board and subcommittees. This includes screening candidates through the defined selection process to present a list of individuals to the Board of Directors and/or at the shareholder meeting for consideration and approval. 2) Propose criteria for evaluating the performance of the committee to the Board of Director to be used in the assessment of overall performance of each committee. 3) Review the succession planning policy to ensure readiness in workforce management and continuous business operations. 4) Consider the model of the remuneration policy and establish appropriate remuneration for the Company's directors and subcommittee members in alignment with the Company's strategies, roles, and responsibilities as stipulated, as well as comparing the remuneration data with other companies in the same industry, which shall be presented to the Board of Directors and/or shareholder meetings for approval. 5) Report to the Board of Directors on the performance of the Nomination and Remuneration Committee. 6) Appoint working groups related to the nomination and remuneration review, ensuring appropriateness, as well as defining roles, responsibilities, and accountability to fulfil the objectives. 7) Perform any other operations related to the nomination and remuneration as assigned by the Board of Directors.
https://www.bangkokchainhospital.com/storage/document/charter/bch-nomination-and-remuneration-committee-charter-en.pdf20.0 · Meeting allowance: 0.0 · Other remuneration: 0.0260 · Last name: SOMBUTSIRI · Position: 37 · First name: SIRIPONG · Total meeting: 2 · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: SUNTRAJARN, M.D. · Position: 39 · First name: THAWAT · Total meeting: 2 · Title other name: Mr. · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0 · 263 · Last name: HARNPHANICH · Position: 39 · First name: PORNSUDA · Total meeting: 2 · Title other name: Dr. · Meeting allowance: 0.0 · Other remuneration: 0.0 · Total remuneration: 0.0 · Total meeting attendance: 2 · Non monetary remuneration: 0 · Total subsidiary remuneration: 0.0

Executives

Executives

TitleTitle — Please SpecifyFirst NameLast NamePositionGenderYear of BirthNationalityResident in Thailand?Appointment DateHighest EducationField of StudySkills & ExpertiseIs the Highest-ranking Executive?Is the Highest-ranking Accounting or Finance Officer?Directly Responsible for Accounting?Appointed After the End of the Fiscal Year?
otherProf. Dr. CHALERMHARNPHANICH, M.D.Chairman of the Executive CommitteeM1,954643 · Description: ThailandY1993-11-24T00:00Doctoral degreeMedicine134 · Description: Health Care Services · 144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business AdministrationYNNN
otherAsst. Prof. Dr. SOMPORNHARNPHANICH, M.D.Deputy Chief Executive OfficerF1,952643 · Description: ThailandY1993-11-24T00:00Doctoral degreeMedicine134 · Description: Health Care Services · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration · 147 · Description: SustainabilityNNNN
otherDr.PORNLUCKHARNPHANICH, M.D.DirectorF1,985643 · Description: ThailandY2012-08-10T00:00Doctoral degreeBusiness Administration134 · Description: Health Care Services · 165 · Description: Risk Management · 1683 · Description: Business Administration · 265 · Description: Governance/ Compliance · 147 · Description: SustainabilityNNNN
Mr.KANTAPORNHARNPHANICHDirectorM1,987643 · Description: ThailandY2015-04-28T00:00Master's degreeBusiness Administration142 · Description: Marketing · 154 · Description: Digital Marketing · 265 · Description: Governance/ Compliance · 1683 · Description: Business AdministrationNNNN
otherDr.PORNSUDA HARNPHANICHDirectorF1,989643 · Description: ThailandY2020-01-13T00:00Doctoral degreeBusiness Administration144 · Description: Finance · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance · 1683 · Description: Business Administration · 147 · Description: SustainabilityNYYN

Executive Remuneration

Monetary Remuneration — Description

The remuneration for the Executive Committee and executives of the Company and its subsidiaries, totaling 22 individuals for the year ended December 31, 2025, including salaries and bonuses, amounts to 218.03 million baht. The payment of remuneration to the Executive Committee and executives adheres to the principles and policies set by the Board of Directors, aligning with the roles and responsibilities assigned and in connection with the Company's turnover and the individual performance of each executive.

Monetary Remuneration

MetricCurrent YearPrevious YearTwo Years Ago
Total remuneration of executive directors and executives (baht)218,033,000216,144,000223,220,000
Total remuneration of executive directors (baht)
Total remuneration of executives (baht)

Other Remuneration

MetricCurrent YearPrevious YearTwo Years Ago
Company’s contribution to provident fund for executive directors and executives (Baht)17,642,917.616,769,405.4816,165,952.72
Employee Stock Ownership Plan (ESOP)000
Employee Joint Investment Program (EJIP)000

Remuneration or Benefits Payable to Executives

MetricAmount (Baht)
Outstanding remuneration or benefits of executive directors and executives in the past year (baht)0
Estimated remuneration of executive directors and executives in the current year (baht)

Remuneration Policy

Executive Remuneration Policy

The Company has established clear and transparent remuneration for its directors, which has been approved at shareholder meetings. The remuneration for directors is set at an appropriate level, aligning with industry standards and commensurate with the roles and responsibilities assigned. The remuneration for executives adheres to principles and policies established by the Board, in connection with the Company's turnover and the individual performance of each executive.


1

1

1

1

Was an Opinion Obtained from the Board and the Remuneration Committee?

Yes

Employees

Any Significant Change in Headcount in the Past 3 Years?

No

Provident Fund

Does the Company Have a Provident Fund?

Yes

Provident Fund Policy

The Company and its subsidiaries have established a provident fund for employees based on their voluntary participation. The Company and its subsidiaries contribute at a rate ranging from 2-15% of the monthly salary of employees. There are 1,457 employees who have joined the provident fund with the Company and its subsidiaries, accounted for 25.61% of total employees.


Policy for Employees Not in the Provident Fund

Automatic Enrolment

No

Encouraging Retirement Saving

No

Providing Investment Information

No

Other Measures

No

Auditors and Audit Fees

How Audit Fees Are Reported

TOTAL

Company Auditor and Fees

Audit FirmAddressSub-districtDistrictProvincePostcodeFaxAuditorsAudit Fee (Baht)Any Non-audit Fee?
KPMG PHOOMCHAI AUDIT COMPANY LIMITEDNo. 1 Empire Tower Building, 50th Floor, Sathorn South Road.YAN NAWASATHONBangkok101200 2677 2222vilaivan@kpmg.co.th · Title: 261 · Regis no: 8420 · Last name: PHOLPRASERT · First name: VILAIVAN · Telephone: 02-677-2325 · vipavan@kpmg.co.th · Title: 261 · Regis no: 4795 · Last name: PATTAVANVIVEK · First name: VIPAVAN · Telephone: 02-677-2331 · marisa@kpmg.co.th · Title: 261 · Regis no: 5752 · Last name: THARATHORNBUNPAKUL · First name: MARISA · Telephone: 02-677-23637,673,000N

Company Secretary and Other Assigned Persons

Company Secretary

TitleFirst NameLast NameEmailTelephone
Mr.VoraveeKiatiniyomsakVoravee.ki@bangkokchainhospital.com02-836-9937

Chief Accountant

TitleFirst NameLast NameEmailTelephone
Mr.VoraveeKiatiniyomsakaccount@Bangkokchainhospital.com02-836-9937

Head of Internal Audit

TitleFirst NameLast NameEmail
Ms.WantaneeWongbutrrodwantani@dir.co.th

Investor Relations Contact

Does the Company Have an Investor Relations Contact?

Yes

Investor Relations Contacts

TitleFirst NameLast NameEmailTelephone
Ms.VimonmarnKrishnakalinir@bangkokchainhospital.com02-836-9940

Representatives in Thailand (Foreign Companies)

Does the Company Have Representatives in Thailand?

No

Contents